Drug-induced QT prolongation and torsades de pointes: evaluation of a QT nomogram.
暂无分享,去创建一个
G K Isbister | C. Kirkpatrick | G. Isbister | A Chan | C M J Kirkpatrick | S B Dufful | A. Chan | S. B. Dufful
[1] Dan M Roden,et al. Drug-induced long QT and torsade de pointes: recent advances , 2007, Current opinion in cardiology.
[2] S. Duffull,et al. Application of pharmacokinetic-pharmacodynamic modelling in management of QT abnormalities after citalopram overdose , 2006, Intensive Care Medicine.
[3] Lena E Friberg,et al. Pharmacokinetic-pharmacodynamic modelling of QT interval prolongation following citalopram overdoses. , 2006, British journal of clinical pharmacology.
[4] V. Piotrovsky,et al. Pharmacokinetic-pharmacodynamic modeling in the data analysis and interpretation of drug-induced QT/QTc prolongation , 2005, The AAPS Journal.
[5] Kimberly Crimin,et al. Dynamic Beat-to-Beat Modeling of the QT-RR Interval Relationship: Analysis of QT Prolongation during Alterations of Autonomic State versus Human Ether a-go-go-Related Gene Inhibition , 2005, Journal of Pharmacology and Experimental Therapeutics.
[6] A. Moss,et al. Assessment of the Stability of the Individual‐Based Correction of QT Interval for Heart Rate , 2005, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.
[7] Peter W Macfarlane,et al. A comparison of commonly used QT correction formulae: the effect of heart rate on the QTc of normal ECGs. , 2004, Journal of electrocardiology.
[8] S. Bowe,et al. Relative Toxicity of Selective Serotonin Reuptake Inhibitors (SSRIs) in Overdose , 2004, Journal of toxicology. Clinical toxicology.
[9] I. Whyte,et al. Quetiapine poisoning: a case series. , 2003, Annals of Emergency Medicine.
[10] F. Segura,et al. QT prolongation and Torsades de Pointes in patients infected with human immunodeficiency virus and treated with methadone. , 2003, The American journal of cardiology.
[11] G. Isbister,et al. Bupropion Overdose: QTc Prolongation and its Clinical Significance , 2003, The Annals of pharmacotherapy.
[12] M. Malik,et al. Variability of heart rate correction methods for the QT interval. , 2003, British journal of clinical pharmacology.
[13] B. Fermini,et al. The impact of drug-induced QT interval prolongation on drug discovery and development , 2003, Nature Reviews Drug Discovery.
[14] J. Coromilas,et al. Amiodarone-Induced Torsade de Pointes During Bladder Irrigation: An Unusual Presentation , 2003, Angiology.
[15] A. Camm,et al. QT-RR relationship in healthy subjects exhibits substantial intersubject variability and high intrasubject stability. , 2002, American journal of physiology. Heart and circulatory physiology.
[16] A. Camm,et al. Relation between QT and RR intervals is highly individual among healthy subjects: implications for heart rate correction of the QT interval , 2002, Heart.
[17] J. Dutcher,et al. Torsades de pointes in 3 patients with leukemia treated with arsenic trioxide. , 2001, Blood.
[18] Morrison Hodges,et al. Rate Correction of the QT Interval , 1997 .
[19] H. Kennedy,et al. Torsades de pointes associated with drugs and toxins: recognition and management. , 1987, American heart journal.
[20] C. Erhardt,et al. INTERPRETATION AND USES OF MEDICAL STATISTICS , 1970 .
[21] A J Camm,et al. Evaluation of Drug-Induced QT Interval Prolongation , 2001, Drug safety.